Contact l Sitemap

home industries issues reasearch weblog press

Home  » Industries » Pharmaceuticals

News Articles : Displaying 61-80 of 161


US: Harvard Researcher Forced Bayer to Disclose Drug Toxicity Study
by Justin Blum and Eva von SchaperBloomberg
October 6th, 2006
Bayer AG's disclosure last week of a study showing that a promising medicine has deadly side effects came only after a Harvard drug safety expert told U.S. regulators that the research existed.

US: Schering-Plough Agrees To Plead Guilty, Pay Fine
by Denise LavoieAssociated Press
August 30th, 2006
Schering-Plough Corp. on Tuesday agreed to pay $435 million and plead guilty to conspiracy to settle a federal investigation into marketing of its drugs for unapproved uses and overcharging Medicaid for certain drugs.

THAILAND: Patent or patient? How Washington uses trade deals to protect drugs
by Alan Beattie, Andrew Jack and Amy KazminThe Financial Times
August 22nd, 2006
As the World Health Organisation's top man in Thailand, William Aldis knew Thai officials were hosting their US counterparts in the northern city of Chiang Mai to negotiate what to many outsiders might seem an entirely worthy objective: a bi­lateral free-trade deal. But he saw dangers - and decided to make his views public.

US: Drug Companies Face Inquiry for Drug Patent
by Stephanie SaulThe New York Times
July 27th, 2006
Two big drug companies that market the best-selling drug Plavix — Sanofi-Aventis and Bristol-Myers Squibb — had been looking for good news this week: an all-clear from the federal government and several states to settle a patent dispute. Instead, they got a notice that the proposed settlement is the subject of a criminal investigation by the Department of Justice.

US: Approval of Antibiotic Worried Safety Officials
by Gardiner HarrisThe New York Times
July 19th, 2006
In an internal review, a federal drug safety official concluded that a controversial antibiotic made by a French drug company should be withdrawn, according to e-mail messages exchanged among top agency officials.

US: Hospital Chiefs Get Paid for Advice on Selling
by Walt Bogdanich The New York Times
July 17th, 2006
One recent sun-splashed afternoon, executives who run some of America's leading nonprofit hospitals met at a stately Colorado resort for an unusual mission: to advise companies confidentially on how best to sell their drugs, medical devices and financial services to hospitals.

WORLD: Prices Soar for Cancer Drugs
by Liz SzaboUSA Today
July 10th, 2006
Spiraling prices for new cancer therapies — up to $10,000 a month for a single drug — are causing alarm among patients and insurance companies.

INDIA: Petri Dish for Pharmaceutical MNCs
by Ann De RonInter Press News Service
July 10th, 2006
Pharmaceutical multinationals, seeking to ramp up profits through cheap drug trials, are increasingly turning to India with its combination of a vast pool of poor, ignorant patients on the one hand and skilled medical personnel and fine research infrastructure on the other.

US: Johnson & Johnson Told to Pay Damages in Pain-Patch Death
Bloomberg News
July 8th, 2006
Jurors in a state court in Houston decided yesterday that Johnson & Johnson, the consumer health care company, must pay $772,500 to the family of a Texas woman who died after a patch intended to release pain-killing drugs leaked.

US: Vioxx 'a Hazard,' Doctor Testifies
The Associated Press
July 6th, 2006
Patients who took the painkiller Vioxx were at risk of heart attacks and strokes — something shown by studies conducted years before the product went on the market, a doctor testified Wednesday.

US: Another Merck Drug Is Under Legal Attack
by Molly SelvinThe Los Angeles Times
July 5th, 2006
As Merck & Co. defends itself against a deluge of litigation involving its pain reliever Vioxx, the pharmaceutical giant also is fielding the first of what could be another wave of lawsuits involving Fosamax, its second-biggest seller.

US: Petitions to FDA Sometimes Delay Generic Drugs
by Marc KaufmanThe Washington Post
July 3rd, 2006
A procedure designed to alert the Food and Drug Administration to scientific and safety issues is getting a hard look from members of Congress, who say they are concerned that it may be getting subverted by the brand-name drug industry.

US: Charities Tied to Doctors Get Drug Industry Gifts
by Reed AbelsonThe New York Times
June 28th, 2006
Around the country, doctors in private practice have set up tax-exempt charities into which drug companies and medical device makers are, with little fanfare, pouring donations — money that adds up to millions of dollars a year. And some medical experts see that as a big problem.

EUROPE: Drug Firms Attacked on Marketing
BBC News
June 27th, 2006
The Consumers International lobby group accused drugmakers of using the methods to get doctors to prescribe products and persuade consumers they need them.

US: Correction to Study Shows Vioxx Risks Appeared Early on
The Associated Press
June 26th, 2006
A correction published Monday to a key study on withdrawn painkiller Vioxx reveals the risk of heart problems was elevated throughout the time people were on the drug and did not develop only after 18 months of use as the drug's maker, Merck & Co., has contended.

US: Drug Firms a Danger to Health – Report
by Sarah BoseleyThe Guardian (UK)
June 26th, 2006
Drug companies are accused today of endangering public health through widescale marketing malpractices, ranging from covertly attempting to persuade consumers that they are ill to bribing doctors and misrepresenting the results of safety and efficacy tests on their products.

US: Merck's Zocor Deal Stirs Ill Will
The Associated Press
June 22nd, 2006
The pharmaceutical firm slashes the price of its cholesterol drug for one insurance plan. Generic maker Teva weighs legal action.

US: Drug Prices Up Sharply This Year
by Milt FreudenheimThe New York Times
June 21st, 2006
Prices of the most widely used prescription drugs rose sharply in this year's first quarter, just as the new Medicare drug coverage program was going into effect, according to separate studies issued yesterday by two large consumer advocacy groups.

US: Drugs firm blocks cheap blindness cure
by Sarah BoseleyThe Guardian
June 17th, 2006
A major drug company is blocking access to a medicine that is cheaply and effectively saving thousands of people from going blind because it wants to launch a more expensive product on the market.

UK: Drugs Firm Blocks Cheap Blindness Cure
by Sarah BoseleyThe Guardian (UK)
June 17th, 2006
A major drug company is blocking access to a medicine that is cheaply and effectively saving thousands of people from going blind because it wants to launch a more expensive product on the market.

Displaying 61-80 of 161  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List »